Trial intelligence / Profile preview

Phenytoin cream crossover trial in painful chronic idiopathic axonal polyneuropathy

NL-OMON55278Phase 2Active, not recruiting

Sponsor
University Medical Center Utrecht
Start
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of phenytoin in chronic idiopathic axonal polyneuropathy (CIAP) (3 arms), sponsored by University Medical Center Utrecht. Started Dec 2020; status: active, not recruiting.

02

Drugs

phenytoin
03

Conditions

chronic idiopathic axonal polyneuropathy (CIAP)

Beyond the preview

Go deeper on NL-OMON55278.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON55278.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call